XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Revenues $ 535,955 $ 554,963 $ 1,098,004 $ 1,127,990
Operating expenses        
Provision for changes in expected cash flows from financial royalty assets 105,714 (243,762) 290,335 48,499
Research and development funding expense 606 3,122 101,106 5,763
Amortization of intangible assets 0 5,733 5,670 11,404
General and administrative expenses 51,843 44,921 103,383 88,077
Total operating expenses/(income), net 158,163 (189,986) 500,494 153,743
Operating income 377,792 744,949 597,510 974,247
Other (income)/expense        
Equity in earnings of equity method investees (737) (17,701) (1,134) (15,783)
Interest expense 46,966 37,426 94,029 74,841
(Gains)/losses on derivative financial instruments (71,805) 1,909 (71,805) 4,464
(Gains)/losses on equity securities (8,024) (55,495) 28,138 (1,309)
Unrealized gains on available for sale debt securities (70,321) (14,015) (53,742) (23,130)
Interest income (10,919) (14,037) (20,448) (30,635)
Other non-operating expense, net 1,035 107 2,792 65
Total other (income)/expenses, net (113,805) (61,806) (22,170) 8,513
Consolidated net income before tax 491,597 806,755 619,680 965,734
Income tax expense 0 0 0 0
Consolidated net income 491,597 806,755 619,680 965,734
Net income attributable to non-controlling interests 187,093 365,979 263,415 455,839
Net income attributable to Royalty Pharma plc $ 304,504 $ 440,776 $ 356,265 $ 509,895
Earnings per Class A ordinary share:        
Basic (in dollars per share) $ 0.70 $ 1.08 $ 0.82 $ 1.28
Diluted (in dollars per share) $ 0.70 $ 1.08 $ 0.82 $ 1.25
Weighted average Class A ordinary shares outstanding:        
Basic (in shares) 436,318 409,344 435,144 399,606
Diluted (in shares) 607,214 607,163 607,207 607,151
Financial Royalty Assets        
Revenues $ 515,350 $ 503,414 $ 1,026,873 $ 1,033,039
Intangible Royalty Assets        
Revenues 2,537 40,127 36,123 76,188
Royalty Income, Other        
Revenues $ 18,068 $ 11,422 $ 35,008 $ 18,763